Li, Yan-Ruide https://orcid.org/0000-0002-9858-300X
Fang, Ying
Niu, Siyue
Zhu, Yichen
Chen, Yuning https://orcid.org/0009-0000-8010-670X
Lyu, Zibai
Zhu, Enbo https://orcid.org/0000-0001-8600-8553
Tian, Yanxin
Huang, Jie
Rezek, Valerie https://orcid.org/0000-0002-2336-7599
Kitchen, Scott https://orcid.org/0000-0001-6182-6082
Hsiai, Tzung https://orcid.org/0000-0003-1734-0792
Zhou, Jin J.
Wang, Pin https://orcid.org/0000-0002-4132-105X
Chai-Ho, Wanxing
Park, Sunmin
Seet, Christopher S. https://orcid.org/0000-0002-4821-1400
Oliai, Caspian
Yang, Lili https://orcid.org/0000-0001-6568-0404
Funding for this research was provided by:
California Institute for Regenerative Medicine (DISC2-11157, TRAN1-12250)
U.S. Department of Defense (CDMRP PRCRP Impact Award (CA200456))
UC | University of California, Los Angeles (UCLA BSCRC Innovation Award, Ablon Scholars Award, UCLA MIMG M. John Pickett Post-Doctoral Fellow Award, CIRM-BSCRC Postdoctoral Fellowship, UCLA Sydney Finegold Postdoctoral Award, UCLA Chancellor’s Award for Postdoctoral Research)
Article History
Received: 25 November 2024
Accepted: 14 January 2025
First Online: 1 February 2025
Competing interests
: Y.-R.L., P.W., and L.Y. are inventors on the patent (Title: Engineered off-the-shelf immune cells and methods of use thereof; identification number: AU2020291457A1) relating to this study filed by UCLA. C.S.S. is a cofounder and stockholder of Pluto Immunotherapeutics. P.W. is a cofounder, stockholder and advisory board member of Simnova Bio, TCRCure Biopharma, Appia Bio, and is a scientific advisor to Grit Biotechnology. L.Y. is a scientific advisor to AlzChem and Amberstone Biosciences, and a co-founder, stockholder, and advisory board member of Appia Bio. Appia Bio licensed some patents relating to this study from UCLA. None of the declared companies contributed to or directed any of the research reported in this article. The remaining authors declare no competing interests.